Articles & Video
The Future of the Global Pharmaceutical Regulatory Affairs Industry
In a new interactive ebook, we take a deep dive into the challenges and trends we may see in pharmaceutical regulatory affairs over the next decade.
Pharma and Medical Device Regulations Content Library: Whitepapers and Reports Collection
Explore our collection of exclusive whitepapers and reports covering the hottest topics in pharma, biotech and medical device regulatory affairs and law with one simple registration.
Life Sciences Survey: COVID-19 Impacts One Year On
Take part in our industry survey on the impacts of COVID-19 on the life sciences one year on to get exclusive early access to the final report.
REPORT: Diversity, Equity and Inclusion in the Life Sciences 2021
Explore the Diversity, Equity and Inclusion in the Life Sciences 2021 report based on an exclusive study of 483 industry professionals.
SURVEY: Diversity, Equity and Inclusion in the Life Sciences 2021
Complete our survey on Diversity, Equity and Inclusion in the Life Sciences 2021 to get exclusive early access to the final report.
Is your Regulatory Information Management process putting your company at risk?
Many companies are putting themselves at risk lacking AI -powered RIM systems for regulatory data management. Get the details in this complimentary article.
Clinical Evaluations for Medical Devices and IVDs - MedTech eBook Series
Discover how the EU MDR will affect clinical evaluations for medical devices and IVDs in this MedTech Summit eBook.
Post-event Report: Global Pharmaceutical Regulatory Affairs Summit 2020
This report takes a detailed look back at the 2020 virtual Global Pharmaceutical Regulatory Affairs Summit.
Report: Partnering And Deal-Making in Pharma through the Pandemic
This Informa report explores how partnering and deal-making in the pharma industry has been impacted by COVID-19.
What is standing in the way of global harmonisation?
Despite many efforts to globalise the pharmaceutical market, why are regulatory affairs still a challenge for drug manufacturers? Figen Kabadas highlights the obstacles.
REPORT: The Future of Healthcare Post COVID-19
In our latest report learn how healthcare organizations are adapting to succeed post COVID-19, from innovation to product development.
Women in Pharma: 44% of pharma professionals think that women are under represented in their organization
44% of pharma professionals think that women are under represented in their organization according to new data from an Informa Connect Life Sciences study. Here we deep dive into the data.
Regulations in Brazil: What the drug approval process is like in 2020
How has Brazil and LATAM adapted pharmaceutical regulations according to COVID-19 and harmonisation with other regions?
SURVEY: Partnering and Deal-Making in Biopharma through the Pandemic
We are conducting a huge study to gauge perspectives around biopharma deal-making during COVID-19 and the commercial ramifications of the pandemic. Take part here.
Barriers and Challenges for Global Regulatory Harmonization
What obstacles are keeping regions such as Latin America from achieving regulatory harmonization with the rest of the world?
Oligonucleotides and peptides: the regulatory challenges
We investigate where current regulatory obstacles lie surrounding peptide and oligonucleotide therapeutics.
Top Biotech Deals in China
Discover the deals transforming China biotech! More than $12 billion in biopharma financing, alliances, IPOs, and new funds have been generated so far this year in China. Learn the details of these deals when you read this new free infographic.
Pharma R&D Annual Review 2020
The researchers and analysts at Pharma Intelligence have taken the guess work out of figuring out how pharmaceutical research and development has progressed over the past few years and what you can expect in 2020. Pharma R&D Annual Review 2020 condenses the thorough analysis of all drugs in development by pharmaceutical companies, from those at the preclinical stage, through the various stages of clinical testing and regulatory approval, and up to and including launch.
80% of life sciences professionals predict a COVID-19 vaccine will be approved within 18 months
How quickly to life sciences professionals predict a COVID-19 vaccine will be approved and what are the main obstacles? We explore.
The EU MDR Delay and Implementation - MedTech eBook Series
Discover the challenges of EU MDR implementation and impacts of the delay on the medical device industry in this MedTech eBook.